HIV-1 ICD p24 antigen detection in Ugandan infants: Use in early diagnosis of infection and as a marker of disease progression

Journal of Medical Virology

Volumn 62, Issue 4, 2000, Pages 426-434

  Guay, Laura A ^a   Hom, David L ^b   Kabengera, Sam R ^c   Piwowar Manning, Estelle M ^a   Kataaha, Peter ^c   Ndugwa, Christopher ^d   Marum, Lawrence H ^a   Kalyesubula, Israel ^d   Jackson, J Brooks ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MINISTRY OF HEALTH   (Uganda)

^d MAKERERE UNIVERSITY   (Uganda)

Author keywords

Africa; Disease progression; Early diagnosis; HIV; p24 antigen; Pediatrics

Indexed keywords

ANTIGEN P24;

ANTIGEN DETECTION; ARTICLE; CHILD; CORRELATION FUNCTION; DISEASE COURSE; EARLY DIAGNOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT MORTALITY; MAJOR CLINICAL STUDY; SURVIVAL; UGANDA; VIRUS DIAGNOSIS;

BIOLOGICAL MARKERS; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; UGANDA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033753270     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(200012)62:4<426::AID-JMV6>3.0.CO;2-S     Document Type: Article

References (40)

1. Serum tumor necrosis factor alpha, interleukin 1-beta, p24 antigen concentrations and CD4+ cells at various stages of human immunedeficiency virus 1 infection in children
2. Relationship between cell-free viraemia, antigenemia, and antibody levels in HIV-1-infected Ethiopian patients
3. Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: A comparison between European and Central African populations
4. Early diagnosis of human immunodeficiency virus infection in children <6 months of age: Comparison of polymerase chain reaction, culture, and plasma antigen capture techniques
5. Predictive markers for mother-to-child transmission of HIV-1 in Dar es Salaam, Tanzania
6. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates
7. Diagnostic utility of immune-complex-dissociated p24 antigen detection in perinatally acquired HIV-1 infection in Rwanda
8. CD4 status and p24 antigenemia: Are they useful predictors of survival in HIV-infected children receiving antiretroviral therapy?
9. Interpretation and use of the western blot assay for serodiagnosis of human immune-deficiency virus type 1 infection
10. 1994 Revised Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age
11. Early diagnosis of human immunodeficiency virus type 1-infected infants by plasma p24 antigen assay after immune complex dissociation
12. HIV-1 RNA detection in plasma for the diagnosis of infection in neonates
13. Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection
14. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus HIV-1 infection
15. Clinical and immunological correlates of immune-complex-dissociated HIV-1 p24 antigen in HIV-1-infected children
16. Natural history of human immunodeficiency virus type 1 infection in children: Prognostic value of laboratory tests on the bimodal progression of the disease
17. Correlation of serum antigen and antibody concentration with clinical features in HIV infection
18. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1
19. Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection
20. HIV-1 Seroprevalence rates in women attending a prenatal clinic in Kampala, Uganda
21. Features of children perinatally infected with HIV-1 surviving longer than 5 years
22. β2-Microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: Predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women
23. Humoral immune response in Epstein-Barr virus infections. II. IgG subclass distribution in African patients with Burkitt's lymphoma and nasopharyngeal carcinoma
24. Sensitivity, specificity and predictive value of physical examination, culture, and other laboratory studies in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection
25. A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus
26. Rapid serologic testing with Immune Complex Dissociated HIV p24 antigen for early detection of HIV infection in neonates
27. Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1 infected children
28. Diagnosis of perinatal human immunodeficiency virus infection by polymerase chain reaction and p24 antigen detection after immune complex dissociation in an urban community hospital
29. Laboratory diagnosis of infection status in infants perinatally exposed to human immunodeficiency virus type 1
30. Immune complex-dissociated p24 antigen in congenital or perinatal HIV infection: Role in the diagnosis and assessment of risk of infection in infants
31. Acid dissociation of immune complexes improves diagnostic utility of p24 antigen detection in perinatally acquired human immunodeficiency virus infection
32. Polymerase chain reaction, virus isolation and antigen assay in HIV-1-antibody-positive mothers and their children
33. Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants
34. Serum levels of soluble CD8, neopterin, β2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy
35. Enhanced p24 Antigen detection in sera from human immunodeficiency virus-infected children
36. HIV type 1 variation in WHO-sponsored vaccine evaluation sites: Genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains
37. Correlation of ribonucleic acid polymerase chain reaction, acid dissociated p24 antigen, and neopterin with progression of disease: A retrospective, longitudinal study of vertically acquired human immunodeficiency virus type 1 infection in children